AbbVie Inc. — M&A Activity 2014

Oct 16, 2014

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D. C. 20549*

*FORM 8-K*

*CURRENT REPORT*

*Pursuant to Section 13 or 15(d) of the*

*Securities Exchange Act of 1934*

Date of Report (Date of earliest event reported): October 15, 2014

*ABBVIE INC.*

(Exact name of registrant as specified in its charter)

Delaware	001-35565	32-0375147
(State or other Jurisdiction	(Commission File Number)	(IRS Employer
of Incorporation)		Identification No.)

*1 North Waukegan Road*

*North Chicago, Illinois 60064-6400*

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (847) 932-7900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\108694\14-18836-17\task7016601\18836-17-ba.htm',USER='108694',CD='Oct 16 10:16 2014'

*Item 8.01. Other Events.*

On October 15, 2014, AbbVie Inc. (“AbbVie”) issued a press release announcing that AbbVie’s board of directors has withdrawn its previous recommendation to AbbVie stockholders in favor of the proposed transaction with Shire plc (“Shire”). The AbbVie board of directors now recommends AbbVie stockholders vote against the Shire transaction.

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 8.01.

*Item 9.01. Financial Statements and Exhibits.*

Exhibit No.	Exhibit
99.1	Press Release, dated October 15, 2014

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\108694\14-18836-17\task7016601\18836-17-ba.htm',USER='108694',CD='Oct 16 10:16 2014'

*SIGNATURE*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ LAURA J. SCHUMACHER
Laura J. Schumacher
Executive Vice President, Business Development, External Affairs and General Counsel

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\108694\14-18836-17\task7016601\18836-17-ba.htm',USER='108694',CD='Oct 16 10:16 2014'

*EXHIBIT INDEX*

Exhibit No.	Exhibit
99.1	Press Release, dated October 15, 2014

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\108694\14-18836-17\task7016601\18836-17-ba.htm',USER='108694',CD='Oct 16 10:16 2014'